Hyloris Pharmaceuticals SA (EBR:HYL)
Belgium · Delayed Price · Currency is EUR 5.98
-0.02 (-0.33%)
Nov 19, 2025, 2:43 PM CET
Hyloris Pharmaceuticals Market Cap
Hyloris Pharmaceuticals has a market cap or net worth of €168 million as of November 19, 2025. Its market cap has increased by 25.00% in one year.
Market Cap
168.00M
Enterprise Value
150.53M
Revenue
8.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
€5.98
Market Cap Chart
Since June 29, 2020, Hyloris Pharmaceuticals's market cap has decreased from 244.70M to 168.00M, a decrease of -31.34%. That is a compound annual growth rate of -6.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2025 | 168.00M | -8.26% |
| Dec 31, 2024 | 183.12M | -48.71% |
| Dec 29, 2023 | 357.00M | 14.84% |
| Dec 30, 2022 | 310.88M | -30.44% |
| Dec 31, 2021 | 446.90M | 82.11% |
| Dec 31, 2020 | 245.41M | 0.29% |
| Jun 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| argenx SE | 47.72B |
| UCB SA | 43.11B |
| Financière de Tubize | 8.95B |
| Fagron NV | 1.52B |
| Ion Beam Applications | 305.54M |
| Onward Medical | 180.75M |
| Nyxoah | 155.92M |
| Sequana Medical NV | 38.18M |